GTF2H5, BICD1, and CLK3 have been reported to be oncogenes in ovarian cancer and hepatocellular carcinoma and are strongly associated with prognosis (Gayarre et al., 2016; Li et al., 2019; Jiang et al., 2020). This evidence concerns the gene GTF2H5 and ovarian carcinoma.